Efficacy and safety of molnupiravir for COVID-19 patients

被引:22
作者
Fatima, Maurish [1 ]
Azeem, Saleha [1 ]
Saeed, Junaid [2 ]
Shahid, Abia [1 ]
Cheema, Huzaifa Ahmad [1 ]
机构
[1] King Edward Med Univ, Dept Med, Lahore 54000, Punjab, Pakistan
[2] Nishtar Med Univ, Dept Med, Lahore, Pakistan
关键词
D O I
10.1016/j.ejim.2022.05.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:118 / 121
页数:4
相关论文
共 9 条
[1]  
Arribas Jose R, 2022, NEJM Evid, V1, pEVIDoa2100044, DOI 10.1056/EVIDoa2100044
[2]   Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach [J].
Dal-Re, Rafael ;
Becker, Soren L. ;
Bottieau, Emmanuel ;
Holm, Soren .
LANCET INFECTIOUS DISEASES, 2022, 22 (08) :E231-E238
[3]  
Higgins J., 2019, Cochrane Handbook for Systematic Reviews of Interventions version 6.4, V2nd
[4]   Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19 [J].
Imran, Mohd ;
Kumar Arora, Mandeep ;
Asdaq, Syed Mohammed Basheeruddin ;
Khan, Shah Alam ;
Alaqel, Saleh I. ;
Alshammari, Mohammed Kanan ;
Alshehri, Mohammed M. ;
Alshrari, Ahmed Subeh ;
Mateq Ali, Alreshidi ;
Al-shammeri, Ahmed Muteb ;
Alhazmi, Bushra Dhuhayyan ;
Harshan, Aishah Ali ;
Alam, Md. Tauquir ;
Abida .
MOLECULES, 2021, 26 (19)
[5]  
Rosenke K, 2022, BIORXIV, DOI [10.1101/2022.02.22.481491, DOI 10.1101/2022.02.22.481491]
[6]   Molnupiravir in COVID-19: A systematic review of literature [J].
Singh, Awadhesh Kumar ;
Singh, Akriti ;
Singh, Ritu ;
Misra, Anoop .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (06)
[7]   Molnupiravir and Its Antiviral Activity Against COVID-19 [J].
Tian, Lili ;
Pang, Zehan ;
Li, Maochen ;
Lou, Fuxing ;
An, Xiaoping ;
Zhu, Shaozhou ;
Song, Lihua ;
Tong, Yigang ;
Fan, Huahao ;
Fan, Junfen .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[8]  
Troth S, 2021, J INFECT DIS, V224, P1442, DOI 10.1093/infdis/jiab362
[9]   What will be the role of molnupiravir in the treatment of COVID-19 infection? COMMENT [J].
Vitiello, Antonio ;
Troiano, Valentina ;
La Porta, Raffaele .
DRUGS & THERAPY PERSPECTIVES, 2021, 37 (12) :579-580